Valuation: Acarix AB

Market Cap 308M 31.95M 27.93M 25.67M 23.93M 45.38M 3.04B 46.07M 120M 1.5B 120M 117M 5.15B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 308M 31.95M 27.93M 25.67M 23.93M 45.38M 3.04B 46.07M 120M 1.5B 120M 117M 5.15B EV / Sales 2026 *
16.1x
EV / Sales 2027 * 4.43x
Free-Float
80.16%
Yield 2026 *
-
Yield 2027 * -
1 day-1.54%
1 week-3.04%
Current month+0.39%
1 month+1.79%
3 months-7.43%
6 months-6.41%
Current year-4.66%
1 week 0.25
Extreme 0.248
0.26
1 month 0.24
Extreme 0.242
0.27
Current year 0.22
Extreme 0.2245
0.33
1 year 0.22
Extreme 0.2245
0.47
3 years 0.17
Extreme 0.1688
0.6
5 years 0.17
Extreme 0.1688
1.87
10 years 0.17
Extreme 0.1688
26.8
Manager TitleAgeSince
Chief Executive Officer - 31/01/2024
Chief Operating Officer 62 30/11/2009
Chief Executive Officer 62 22/02/2018
Director TitleAgeSince
Director/Board Member 61 31/12/2019
Director/Board Member 50 13/05/2024
Director/Board Member - 13/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-1.54%-3.04%-23.73%-54.70% 31.9M
-1.95%+1.16%+3.00%-28.72% 16.67B
+5.89%+17.22%+43.79%+99.43% 1.68B
+0.39%+34.99%-39.53%-77.97% 1.24B
+0.06%+3.85%-28.59%+34.44% 1.14B
+1.31%-0.09%-25.81%-52.92% 631M
+0.21%-0.98%-39.13%-56.82% 580M
-0.66%+3.11%+21.67%-54.99% 447M
+1.79%+0.16%-55.37%-60.09% 375M
+2.52%+7.65%-20.35%-17.75% 353M
Average +0.91%+5.71%-16.40%-27.01% 2.32B
Weighted average by Cap. -0.99%+3.68%-0.69%-21.19%

Financials

2026 *2027 *
Net sales 19.1M 1.98M 1.73M 1.59M 1.48M 2.81M 189M 2.86M 7.43M 92.69M 7.43M 7.27M 319M 69.5M 7.21M 6.3M 5.79M 5.4M 10.24M 686M 10.39M 27.02M 337M 27.05M 26.47M 1.16B
Net income -28.9M -3M -2.62M -2.41M -2.24M -4.26M -285M -4.32M -11.23M -140M -11.25M -11.01M -483M 2.4M 249K 218K 200K 186K 353K 23.69M 359K 933K 11.65M 934K 914K 40.13M
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change Volume
03/07/26 SEK 0.2555 -1.54% 719,794
02/07/26 SEK 0.2595 +0.78% 363,272
01/07/26 SEK 0.2575 +1.18% 257,408
30/06/26 SEK 0.2545 -0.59% 678,038
29/06/26 SEK 0.2560 -2.85% 703,491

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACARIX Stock